Literature DB >> 8215361

Trypsin-dependent production of an antibacterial substance by a human Peptostreptococcus strain in gnotobiotic rats and in vitro.

F Ramare1, J Nicoli, J Dabard, T Corring, M Ladire, A M Gueugneau, P Raibaud.   

Abstract

An antibacterial substance appeared within 1 day in feces of gnotobiotic rats harboring a human intestinal Peptostreptococcus strain. It disappeared when the rat bile-pancreatic duct was ligatured or when the rats ingested a trypsin inhibitor. Anaerobic cultures of the Peptostreptococcus strain in a medium supplemented with trypsin also exhibited an antibacterial activity, which was also inhibited by the trypsin inhibitor. In vitro the antibacterial substance from both feces and culture medium was active against several gram-positive bacteria, including other Peptostreptococcus spp., potentially pathogenic Clostridium spp. such as C. perfringens, C. difficile, C. butyricum, C. septicum, and C. sordellii, Eubacterium spp., Bifidobacterium spp., and Bacillus spp. Whatever the order of inoculation of the strains, a sensitive strain of C. perfringens was eliminated within 1 day from the intestine of rats monoassociated with the Peptostreptococcus strain. These findings demonstrate for the first time that very potent antibacterial substances can be produced through a mechanism involving intestinal bacteria and exocrine pancreatic secretions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8215361      PMCID: PMC182380          DOI: 10.1128/aem.59.9.2876-2883.1993

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  11 in total

1.  [Variations in the enzyme content of the rat pancreas as a function of the composition of the diet].

Authors:  J P REBOUD; A BEN ABDEL JLIL; P DESNUELLE
Journal:  Biochim Biophys Acta       Date:  1962-04-09

2.  [Pancreatic secretion by fistulated swine. Adaptation to protein content of the diet].

Authors:  T Corring; R Saucier
Journal:  Ann Biol Anim Biochim Biophys       Date:  1972

3.  Antagonisms among isogenic strains of Escherichia coli in the digestive tracts of gnotobiotic mice.

Authors:  Y Duval-Iflah; P Raibaud; M Rousseau
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

4.  [Transit through the digestive tract of the inocula of several bacterial strains introduced "per Os" into axenic and "Holoxenic" mice. The antagonistic effect of the microflora of the gastrointestinal tract].

Authors:  R Ducluzeau; M Bellier; P Raibaud
Journal:  Zentralbl Bakteriol Orig       Date:  1970-05

5.  Inhibition of Clostridium perfringens by an antibiotic substance produced by Bacillus licheniformis in the digestive tract of gnotobiotic mice: effect on other bacteria from the digestive tract.

Authors:  R Ducluzeau; F Dubos; P Raibaud; G D Abrams
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

6.  The inhibition of the growth of Clostridium welchii by lipids isolated from the contents of the small intestine of the pig.

Authors:  R Fuller; J H Moore
Journal:  J Gen Microbiol       Date:  1967-01

7.  Antagonism exerted by an association of a Bacteroides thetaiotaomicron strain and a Fusobacterium necrogenes strain against Clostridium perfringens in gnotobiotic mice and in fecal suspensions incubated in vitro.

Authors:  N Yurdusev; M Ladire; R Ducluzeau; P Raibaud
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

8.  Studies on the effect of bile salt and colipase on enzymatic lipolysis. Improved method for the determination of pancreatic lipase and colipase.

Authors:  J Rathelot; R Julien; P Canioni; C Coeroli; L Sarda
Journal:  Biochimie       Date:  1975       Impact factor: 4.079

9.  Antibacterial activity of the pancreatic fluid.

Authors:  E Rubinstein; Z Mark; J Haspel; G Ben-Ari; Z Dreznik; D Mirelman; A Tadmor
Journal:  Gastroenterology       Date:  1985-04       Impact factor: 22.682

10.  Interrelationships between digestive proteolytic activities and production and quantitation of toxins in pseudomembranous colitis induced by Clostridium difficile in gnotobiotic mice.

Authors:  G Corthier; M C Muller; G W Elmer; F Lucas; F Dubos-Ramaré
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

View more
  21 in total

Review 1.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

2.  A Lactobacillus acidophilus strain of human gastrointestinal microbiota origin elicits killing of enterovirulent Salmonella enterica Serovar Typhimurium by triggering lethal bacterial membrane damage.

Authors:  Marie-Hélène Coconnier-Polter; Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

3.  The unusual structure of Ruminococcin C1 antimicrobial peptide confers clinical properties.

Authors:  Clarisse Roblin; Steve Chiumento; Olivier Bornet; Matthieu Nouailler; Christina S Müller; Katy Jeannot; Christian Basset; Sylvie Kieffer-Jaquinod; Yohann Couté; Stéphane Torelli; Laurent Le Pape; Volker Schünemann; Hamza Olleik; Bruno De La Villeon; Philippe Sockeel; Eric Di Pasquale; Cendrine Nicoletti; Nicolas Vidal; Leonora Poljak; Olga Iranzo; Thierry Giardina; Michel Fons; Estelle Devillard; Patrice Polard; Marc Maresca; Josette Perrier; Mohamed Atta; Françoise Guerlesquin; Mickael Lafond; Victor Duarte
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

4.  Trypsin mediates growth phase-dependent transcriptional tegulation of genes involved in biosynthesis of ruminococcin A, a lantibiotic produced by a Ruminococcus gnavus strain from a human intestinal microbiota.

Authors:  Ana Gomez; Monique Ladiré; Françoise Marcille; Michel Fons
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

5.  Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces.

Authors:  J Dabard; C Bridonneau; C Phillipe; P Anglade; D Molle; M Nardi; M Ladiré; H Girardin; F Marcille; A Gomez; M Fons
Journal:  Appl Environ Microbiol       Date:  2001-09       Impact factor: 4.792

Review 6.  HUMAN MICROBIOTA. Small molecules from the human microbiota.

Authors:  Mohamed S Donia; Michael A Fischbach
Journal:  Science       Date:  2015-07-23       Impact factor: 47.728

7.  Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity.

Authors:  V Liévin; I Peiffer; S Hudault; F Rochat; D Brassart; J R Neeser; A L Servin
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

8.  Functional analysis of family GH36 α-galactosidases from Ruminococcus gnavus E1: insights into the metabolism of a plant oligosaccharide by a human gut symbiont.

Authors:  M Cervera-Tison; L E Tailford; C Fuell; L Bruel; G Sulzenbacher; B Henrissat; J G Berrin; M Fons; T Giardina; N Juge
Journal:  Appl Environ Microbiol       Date:  2012-08-24       Impact factor: 4.792

9.  Distribution of genes encoding the trypsin-dependent lantibiotic ruminococcin A among bacteria isolated from human fecal microbiota.

Authors:  F Marcille; A Gomez; P Joubert; M Ladiré; G Veau; A Clara; F Gavini; A Willems; M Fons
Journal:  Appl Environ Microbiol       Date:  2002-07       Impact factor: 4.792

Review 10.  Gut Microbiota is an Important Source of Bacteriocins and Their In Situ Expression Can Be Explored for Treatment of Bacterial Infections.

Authors:  Djamel Drider
Journal:  Probiotics Antimicrob Proteins       Date:  2021-09-14       Impact factor: 4.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.